Welcome to LookChem.com Sign In|Join Free

CAS

  • or

34209-81-9

Post Buying Request

34209-81-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

34209-81-9 Usage

General Description

16,17-Epoxypregnenolone acetate is a synthetic chemical compound that has been studied for its potential use in cancer therapy. It is a derivative of the hormone pregnenolone and has been found to exhibit anti-tumor activity in preclinical studies. Research suggests that 16,17-Epoxypregnenolone acetate may have the ability to inhibit the growth of cancer cells by inducing apoptosis, or programmed cell death. It has also been shown to inhibit angiogenesis, the formation of new blood vessels, which is essential for tumor growth and spread. These findings suggest that 16,17-Epoxypregnenolone acetate may hold promise as a potential anticancer agent, although further research is needed to fully understand its mechanisms of action and potential clinical applications.

Check Digit Verification of cas no

The CAS Registry Mumber 34209-81-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,2,0 and 9 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 34209-81:
(7*3)+(6*4)+(5*2)+(4*0)+(3*9)+(2*8)+(1*1)=99
99 % 10 = 9
So 34209-81-9 is a valid CAS Registry Number.
InChI:InChI=1/C23H32O4/c1-13(24)23-20(27-23)12-19-17-6-5-15-11-16(26-14(2)25)7-9-21(15,3)18(17)8-10-22(19,23)4/h5,16-20H,6-12H2,1-4H3

34209-81-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (E0015)  16,17-Epoxypregnenolone Acetate  >95.0%(GC)

  • 34209-81-9

  • 100mg

  • 130.00CNY

  • Detail

34209-81-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 16,17-Epoxypregnenolone acetate

1.2 Other means of identification

Product number -
Other names 3b-Acetoxy-16a,17a-Epoxy-5-Pregnen-20-One

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:34209-81-9 SDS

34209-81-9Relevant articles and documents

Bismuth(III) triflate-catalyzed rearrangement of 16α,17α-epoxy-20-oxosteroids. Synthesis and structural elucidation of new 16α-substituted 17α-alkyl-17β-methyl-Δ13-18-norsteroids

Pinto, Rui M.A.,Salvador, Jorge A.R.,Le Roux, Christophe,Carvalho, Rui A.,Beja, Ana Matos,Paix?o, José A.

, p. 6169 - 6178 (2009)

The use of bismuth(III) triflate for the rearrangement of 16α,17α-epoxy-20-oxosteroids is reported. The reactions occur under truly catalytic conditions to afford novel 17α-alkyl-17β-methyl-Δ13-18-nor products bearing different O-containing substituents at C16. When the reaction is performed in the absence of acylation agent a mixture of isomeric 16α- and 16β-hydroxy derivatives is obtained, whereas when carried out in the presence of such reagents, the reaction selectively affords the corresponding 16α-acyl rearranged products. The chemoselective rearrangement of 5β,6β;16α,17α-diepoxy-20-oxopregnan-3β-yl acetate to afford a 'backbone' rearranged product bearing the 16α,17α-epoxide group is also reported. Some mechanistic considerations are provided. All rearranged products were the subject of comprehensive structural elucidation, by the use of X-ray crystallography and 2D NMR.

Evaluation of new pregnane derivatives as 5α-reductase inhibitor

Cabesa,Heuze,Bratoeff,Ramirez,Martinez

, p. 525 - 530 (2007/10/03)

The objective of this study was to synthesize several new pregnane derivatives and evaluate them as antiandrogens. From the commercially available 16-dehydropregnenolone acetate (7), two new steroidal compounds were synthesized: 17α-hydroxy-17β-methyl-16β-phenyl-D-homoandrosta-1,4.6- triene-3,20-dione (18) and 17α-acetoxy-17β-methyl-16β-phenyl-D-homoandrosta-1,4.6- triene-3,20-dione (19). The 5α-reductase inhibitory effect of the new compounds 18 and 19 together with the previously synthesized intermediates 7, 8, 13, 16, and 17 was determined in three different models: gonadectomized hamster flank organs diameter size, incorporation of [1,2-14C]sodium acetate into lipids in flank organs and conversion of [3H]testosterone (T) to [3H]dihydrotestosterone (DHT) by Penicillium crustosum. The evaluation of these steroids was carried out with three different controls: one group was treated with vehicle, the second with T and the third group with T plus finasteride. The pharmacological results from this work demonstrated that T significantly increases the diameter of the pigmented spot on the flank organs (p3H]T to [3H]DHT in a manner comparable to that of the flank organs. All experiments indicated that finasteride as well as steroids 7, 8, 13, 16-19 reduced significantly the conversion of T to DHT in P. crustosum. These compounds also decrease the size of the pigmented spot in the flank organs as well as reducing the incorporation of radiolabeled sodium acetate into lipids; T and the control sample (treated with vehicle only) were used for comparison. Apparently the presence of the 4,6-diene-3,20-dione moiety and also the C-17 ester group produce a higher inhibitory effect on the parameters used. PPThe data from this study indicated also that the three models used for the pharmacological evaluation exhibited comparable results.

17α-acetoxy-17β-methyl-16β-phenyl-D-homo-4,6-pregnadiene-3, 17a-dione: Synthesis and crystal structure determination of a new rearranged pregnane derivative

Soriano-Garcia, Manuel,Hernandez-Ortega, Simon,Bratoeff, Eugene,Valencia, Norma,Ramirez, Elena,Flores, Gregoria

, p. 487 - 491 (2007/10/03)

The title compound is C29H34O4, tetragonal, P43, a = b = 10.310(1), c = 23.871(2)A. The A, B, C, and D rings adopt envelope, half-chair, chair, and distorted chair conformations, respectively. The phenyl ring is planar. The methyl substituents at the A/B, C/D, and at C(17) are axial; and the -OCOCH3 group at C(17) and phenyl ring at C(16) are equatorial. The molecules in the crystal are held together by van der Waals forces and several C - H···O hydrogen bond interactions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 34209-81-9